Related Experiment Video

Updated: Jul 9, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis

1

  • 1MRC Clinical Trials Unit, 222 Euston Road, London NW1 2DA, UK.

AIDS (London, England)
|December 20, 2007
PubMed

Insights

CD4 counts are key indicators of mortality risk in untreated HIV-infected children. Malnutrition and anemia also significantly impact survival, especially in younger children, highlighting the need for comprehensive care.

Area of Science:

  • Pediatric Infectious Diseases
  • Global Health
  • HIV/AIDS Research

Background:

  • Untreated HIV infection poses significant short-term mortality risks in children, particularly in resource-limited settings.
  • Accurate prognostic markers are crucial for timely intervention and improved survival rates.
  • Existing research often lacks comprehensive data from diverse resource-limited environments.

Purpose of the Study:

  • To determine the prognostic value of laboratory and growth markers for short-term mortality in children with untreated HIV.
  • To identify key predictors of mortality in resource-limited settings.
  • To inform clinical management and public health strategies for pediatric HIV care.

Main Methods:

  • A meta-analysis of individual longitudinal data from 10 studies (9 African, 1 Brazilian) involving children aged 12 months and older.
  • Poisson regression models were used to estimate mortality risk within 12 months, adjusted for cotrimoxazole prophylaxis and study effects.
  • Analysis focused on the most recent measurements of laboratory markers (e.g., CD4%, CD4 count, hemoglobin) and growth parameters (e.g., weight-for-age z-score).

Main Results:

  • CD4% and CD4 cell count were the strongest predictors of mortality, followed by weight-for-age and hemoglobin.
  • Severe malnutrition and anemia in young children (1-2 years) were associated with high mortality, irrespective of CD4 values.
  • High CD4% or CD4 cell count predicted low mortality in children over 5 years or younger children without severe malnutrition or anemia.

Conclusions:

  • CD4 measurements are the most critical indicator for mortality risk in HIV-infected children.
  • Affordable and accessible CD4 testing is essential in resource-limited settings.
  • Antiretroviral therapy initiation should consider weight-for-age and hemoglobin; preventing malnutrition and anemia is vital for improving pediatric HIV survival.
Abstract

More Related Videos

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...